Brooklyn Roasting Company Pasteurized Cold Brew Concentrate Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Brooklyn Roasting Works LLC is recalling 1,219 units of Pasteurized Cold Brew Concentrate due to potential Clostridium botulinum toxin formation.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 11, 2026 and geographically references New York and New Jersey. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Food.
What Happened
Brooklyn Roasting Works LLC is voluntarily recalling the product because ambient storage may lead to Clostridium botulinum toxin formation.
Which Products Are Affected
Brooklyn Roasting Company Pasteurized Cold Brew Concentrate, 2.5gal bag in a box, distributed between 04/01/2026 and 06/20/2026 in NY and NJ. Best By codes range from 063026 through 093026. 1,219 units affected. Recall number H-1179-2026.
What You Should Do
Consumers should check Best By codes on affected units distributed in NY and NJ.
Why This Matters
The Class II recall addresses a hazard that may cause temporary or reversible adverse health consequences.
Source
FDA recall H-1179-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (693 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 11, 2026.
Frequently Asked Questions
Common questions about this FDA recall.